An animal model for acute and persistent Epstein-Barr virus infection
- PMID: 9197263
- DOI: 10.1126/science.276.5321.2030
An animal model for acute and persistent Epstein-Barr virus infection
Abstract
Epstein-Barr virus (EBV) is a human lymphocryptovirus that causes infectious mononucleosis, persists asymptomatically for life in nearly all adults, and is associated with the development of B cell lymphomas and nasopharyngeal carcinomas. A highly similar rhesus lymphocryptovirus naturally endemic in rhesus monkeys was used to orally infect naïve animals from a pathogen-free colony. This animal model reproduced key aspects of human EBV infection, including oral transmission, atypical lymphocytosis, lymphadenopathy, activation of CD23(+) peripheral blood B cells, sustained serologic responses to lytic and latent EBV antigens, latent infection in the peripheral blood, and virus persistence in oropharyngeal secretions. This system may be useful for studying the pathogenesis, prevention, and treatment of EBV infection and associated oncogenesis.
Similar articles
-
Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challenge.PLoS Pathog. 2011 Oct;7(10):e1002308. doi: 10.1371/journal.ppat.1002308. Epub 2011 Oct 20. PLoS Pathog. 2011. PMID: 22028652 Free PMC article.
-
Cloning of the rhesus lymphocryptovirus viral capsid antigen and Epstein-Barr virus-encoded small RNA homologues and use in diagnosis of acute and persistent infections.J Clin Microbiol. 2000 Sep;38(9):3219-25. doi: 10.1128/JCM.38.9.3219-3225.2000. J Clin Microbiol. 2000. PMID: 10970361 Free PMC article.
-
An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection.PLoS Pathog. 2012 Dec;8(12):e1003095. doi: 10.1371/journal.ppat.1003095. Epub 2012 Dec 27. PLoS Pathog. 2012. PMID: 23300447 Free PMC article.
-
A new animal model for Epstein-Barr virus pathogenesis.Curr Top Microbiol Immunol. 2001;258:201-19. doi: 10.1007/978-3-642-56515-1_13. Curr Top Microbiol Immunol. 2001. PMID: 11443863 Review. No abstract available.
-
Non-human Primate Lymphocryptoviruses: Past, Present, and Future.Curr Top Microbiol Immunol. 2015;391:385-405. doi: 10.1007/978-3-319-22834-1_13. Curr Top Microbiol Immunol. 2015. PMID: 26428382 Review.
Cited by
-
Establishment of latent Epstein-Barr virus infection and stable episomal maintenance in murine B-cell lines.J Virol. 2001 Mar;75(6):3016-20. doi: 10.1128/JVI.75.6.3016-3020.2001. J Virol. 2001. PMID: 11222728 Free PMC article.
-
Glycoprotein B Antibodies Completely Neutralize EBV Infection of B Cells.Front Immunol. 2022 May 27;13:920467. doi: 10.3389/fimmu.2022.920467. eCollection 2022. Front Immunol. 2022. PMID: 35711430 Free PMC article.
-
Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challenge.PLoS Pathog. 2011 Oct;7(10):e1002308. doi: 10.1371/journal.ppat.1002308. Epub 2011 Oct 20. PLoS Pathog. 2011. PMID: 22028652 Free PMC article.
-
Antibodies to lytic infection proteins in lymphocryptovirus-infected rhesus macaques: a model for humoral immune responses to epstein-barr virus infection.Clin Vaccine Immunol. 2011 Sep;18(9):1427-34. doi: 10.1128/CVI.05126-11. Epub 2011 Jul 6. Clin Vaccine Immunol. 2011. PMID: 21734064 Free PMC article.
-
Humanized mouse models of epstein-barr virus infection and associated diseases.Pathogens. 2013 Mar 14;2(1):153-76. doi: 10.3390/pathogens2010153. Pathogens. 2013. PMID: 25436886 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
